REG - Warpaint London PLC - AGM Statement

Warpaint LondonAnnouncement

21/05/2019 11:00

RNS Number : 7010Z
Warpaint London PLC
21 May 2019
 


21 May 2019
Warpaint London plc
("Warpaint London" or the "Company" or the "Group")
AGM Statement
 
Warpaint London plc (AIM: W7L), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands, announces that at the Annual General Meeting of the Company to be held today, Clive Garston, Chairman of the Company, will make the following statement:
"I am pleased to report that the outlook for the Company remains in line with that reported at the time of the release of our annual results for the year ended 31 December 2018 on 10 April 2019.
"Whilst trading conditions remain challenging in the UK, we continue to see encouraging international sales growth, in particular in the EU and the US.
"The Group has a sound financial footing and we are actively implementing our strategy for growth.  We look forward to the remainder of the year with cautious optimism."
 
Enquiries:




Warpaint London PLC    
Sam Bazini - Joint Chief Executive Officer
Eoin Macleod - Joint Chief Executive Officer
Neil Rodol - Chief Financial Officer


c/o IFC
 




 
Stockdale Securities Limited (Nominated Adviser and Broker)
Antonio Bossi- Corporate Finance
Fiona Conroy - Corporate Broking


 
020 7601 6100




 
IFC Advisory Limited (Financial PR & IR)
Tim Metcalfe
Heather Armstrong
Florence Chandler


 
020 3934 6630
 




 
Warpaint London plc
 
Warpaint London is a colour cosmetics business, based in Iver, Buckinghamshire. It is made up of two divisions: own brand and close-out.  The larger own brand division primarily consists of the Group's flagship brand, W7, together with the Technic, Body Collection and Man'stuff brands acquired through the acquisition of Retra Holdings in 2017.
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMCKDDDCBKKAPB